Voyager Therapeutics
VYGR
#7478
Rank
โ‚น26.67 B
Marketcap
โ‚น488.33
Share price
1.05%
Change (1 day)
-30.76%
Change (1 year)

P/E ratio for Voyager Therapeutics (VYGR)

P/E ratio as of December 2024 (TTM): 2.41

According to Voyager Therapeutics 's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 2.40586. At the end of 2022 the company had a P/E ratio of -5.04.

P/E ratio history for Voyager Therapeutics from 2015 to 2023

PE ratio at the end of each year

Year P/E ratio Change
2022-5.04253.45%
2021-1.43-119.55%
20207.30-165.9%
2019-11.1225.08%
2018-3.41-45.22%
2017-6.22-22.89%
2016-8.06-20.63%
2015-10.2

P/E ratio for similar companies or competitors

Company P/E ratio P/E ratio differencediff. Country
-3.77-256.54%๐Ÿ‡บ๐Ÿ‡ธ USA

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.